Tech Company Financing Transactions
Nuvig Therapeutics Funding Round
Nuvig Therapeutics, based in Redwood City, received $47 million from Novo Ventures, Platanus Ventures and Bristol-Myers Squibb.
Transaction Overview
Company Name
Announced On
5/12/2022
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Series A
Investors
Novo Ventures (Lead Investor)
Platanus Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1775 Woodside Rd. 201
Redwood City, CA 94061
USA
Redwood City, CA 94061
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to bring innovative and transformational therapies to patients with chronic autoimmune diseases, via induction of mechanisms that restore immune homeostasis. Our first product candidate is a recombinant protein that selectively activates a class of immune regulatory receptors that are naturally involved in rebalancing immune function following inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pamela Conley
Vice President
Greg Coffey
VP - Operations
Heidi Remsberg
Browse more venture capital transactions:
Prev: 5/12/2022: LootLocker venture capital transaction
Next: 5/12/2022: Mathison venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs